Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202302331 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Danial Khorsandi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, California, 91367, USA. Hauptthemen laut MEDLINE: Organoids, Neoplasms. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHLBI NIH HHS, NCATS NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Patient‐derived organoids (PDOs) developed ex vivo and in vitro are increasingly used for therapeutic screening. They provide a more physiologically relevant model for drug discovery and development compared to traditional cell lines. However, several challenges remain to be addressed to fully realize the potential of PDOs in therapeutic screening. This paper summarizes recent advancements in PDO development and the enhancement of PDO culture models. This is achieved by leveraging materials engineering and microfabrication technologies, including organs‐on‐a‐chip and droplet microfluidics. Additionally, this work discusses the application of PDOs in therapy screening to meet diverse requirements and overcome bottlenecks in cancer treatment. Furthermore, this work introduces tools for data processing and analysis of organoids, along with their microenvironment. These tools aim to achieve enhanced readouts. Finally, this work explores the challenges and future perspectives of using PDOs in drug development and personalized screening for cancer patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bioengineering, Terasaki Institute for Biomedical Innovation (TIBI), 1018 Westwood Blvd, Los Angeles, California, 91367, USA.
- Department of Electrical and Computer Engineering, University of British Columbia, Vancouver, BC, V6T 1Z4, Canada.
- Department of Textile Engineering, Amirkabir University of Technology (Tehran Polytechnic), Hafez Avenue, Tehran, 1591634311, Iran.
- Department of Biology, California State University Northridge, 18111 Nordhoff Street, Northridge, California, 91330, USA.
- Rush Center for Integrated Microbiome and Chronobiology Research, Rush Medical College, Rush University Medical Center, Chicago, IL, 60612, USA.
- Department of Pathology, Duke University School of Medicine, Durham, NC, 27710, USA.
ORCID-Profile: Danial Khorsandi, Ankit Gangrade, Yangzhi Zhu, Vadim Jucaud, Mehmet Remzi Dokmeci, Xiling Shen, Faraz Bishehsari, Jonathan A Kelber, Ali Khademhosseini, Natan Roberto de Barros
Förderung
- NCI NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
- National Institutes of Health, National Cancer Institute
- Terasaki Institute for Biomedical Innovation
- National Science and Technology Council
Zitieren
APA
Khorsandi, D., Yang, J. W., Foster, S., Khosravi, S., Hosseinzadeh Kouchehbaghi, N., Zarei, F., Lee, Y. B., Runa, F., Gangrade, A., Voskanian, L., Adnan, D., Zhu, Y., Wang, Z., Jucaud, V., Dokmeci, M. R., Shen, X., Bishehsari, F., Kelber, J. A., Khademhosseini, A., & de Barros, N. R. (2024). Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202302331
Vancouver
Khorsandi D, Yang JW, Foster S, Khosravi S, Hosseinzadeh Kouchehbaghi N, Zarei F, et al. Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202302331
BibTeX
@article{Khorsandi2024,
author = {Khorsandi, Danial and Yang, Jia-Wei and Foster, Samuel and Khosravi, Safoora and Hosseinzadeh Kouchehbaghi, Negar and Zarei, Fahimeh and Lee, Yun Bin and Runa, Farhana and Gangrade, Ankit and Voskanian, Leon and Adnan, Darbaz and Zhu, Yangzhi and Wang, Zhaohui and Jucaud, Vadim and Dokmeci, Mehmet Remzi and Shen, Xiling and Bishehsari, Faraz and Kelber, Jonathan A and Khademhosseini, Ali and de Barros, Natan Roberto},
title = {Patient‐Derived Organoids as Therapy Screening Platforms in Cancer Patients},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202302331}
}
EUVIMED